Behçet's disease as a systemic disease

Clinics in Dermatology

Volumn 32, Issue 3, 2014, Pages 435-442

  Mat, M Cem ^a   Sevim, Ayşegül ^a   Fresko, Izzet ^a   Tüzün, Yalçin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B51 ANTIGEN;

ABDOMINAL PAIN; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ANEURYSM; APHTHOUS STOMATITIS; ARTHRITIS; BEHCET DISEASE; BUDD CHIARI SYNDROME; CAVA VEIN DISEASE; CEREBRAL SINUS THROMBOSIS; CLINICAL FEATURE; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; ERYTHEMA NODOSUM; GASTROINTESTINAL HEMORRHAGE; GENITAL ULCER; HEREDITY; HUMAN; INFLAMMATORY BOWEL DISEASE; NAUSEA; NOTE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PUSTULE; RECURRENT DISEASE; RETINITIS; SUPERFICIAL THROMBOPHLEBITIS; SYSTEMIC DISEASE; UVEITIS; VENA CAVA THROMBOSIS; VISUAL IMPAIRMENT; VOMITING; ARTHRALGIA; BEHCET SYNDROME; CENTRAL NERVOUS SYSTEM DISEASE; COMPLICATION; GENETICS; INFLAMMATION; PATHOLOGY;

ARTHRALGIA; ARTHRITIS; BEHCET SYNDROME; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; INFLAMMATION;

EID: 84898877873     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2013.11.012     Document Type: Note

References (73)

1. Behçet H. Über rezidivierende aphthöse, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Monatsschr 1937, 105:1152-1157.
2. Behçet H., Gözcü N. Üç nahiyede nüksi tavazzular yapan, ve hususi bir virus tesiri ile umumi intan hasil ettiǧine kanaatimiz artan (Entite morbide) hakkinda. Deri Hastaliklari ve Frengi Arşivi 1938, 5:1863-1873.
3. Kartal Durmazlar S.P., Kandi B. Naming dilemma of Behçet's disease. J Turk Acad Dermatol 2011, 5(1). Jtad151r1.pdf.
4. Cho S.B., Cho S., Bang D. New insights in clinical understanding of Behçet's disease. Yonsei Med J 2012, 53:35-42.
5. Yurdakul S., Yazici Y. Epidemiology of Behçet's syndrome and regional differences in disease expression. Behçet's Syndrome 2010, 35-52. Springer, New York. 1st ed. Y. Yazici, H. Yazici (Eds.).
6. Gül A., Ohno S. Genetics of Behçet's disease. Behçet's Syndrome 2010, 265-276. Springer, New York. 1st ed. Y. Yazici, H. Yazici (Eds.).
7. Verity D.H., Marr J.E., Ohno S., Wallace G.R., Stanford M.R. Behçet's disease, the Silk road and HLA-51: historical and geograhical perspectives. Tissue Antigens 1999, 54:213-220.
8. Yurdakul S., Günaydin I., Tüzün Y., et al. The prevalence of Behçet's syndrome in a rural area in northern Turkey. J Rheumatol 1988, 15:820-822.
9. Tüzün Y., Yurdakul S., Cem Mat M., et al. Epidemiology of Behçet's syndrome in Turkey. Int J Dermatol 1996, 35:618-620.
10. Azizlerli G., Köse A.A., Sarica R., et al. Prevalence of Behçet's disease in İstanbul Turkey. Int J Dermatol 2003, 42:803-806.
11. Cakir N., Dervis E., Benian O., et al. The prevalence of Behçet's disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol 2004, 22:53-55.
12. Idil A., Gürler A., Boyvat A., et al. The prevalence of Behçet's disease above age of 10 years. The result of a pilot study conducted at the Park primary Health Care Center in Ankara Turkey. Ophthalmic Epidemiol 2002, 9:325-331.
13. Seyahi E., Tahir Turanli E., Mangan M.S., et al. The prevalence of Behçet's syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul Turkey. Clin Exp Rheumatol 2010, 28:67-75.
14. Mahr A., Belarbi L., Wechsler B., et al. Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008, 58:3951-3959.
15. Ideguchi H., Suda A., Takeno M., Ueda A., Ohno S., Ishigatsubo Y. Behçet disease: evolution of clinical manifestations. Medicine (Baltimore) 2011, 90:125-132.
16. Yazici H., Tüzün Y., Pazarli H., et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 1984, 43:783-789.
17. Yazici H., Tüzün Y., Pazarli H., et al. The long-term mortality and morbidity of Behçet's syndrome: a 2-decade outcome survey of 387 patients followed at dedicated center. Medicine (Baltimore) 2003, 82:60-76.
18. Gürler A., Boyvat A., Tursen U. Clinical manifestations of Behçet's disease. An analysis of 2147 patients. Yonsei Med J 1997, 38:423-427.
19. Alpsoy E., Donmez L., Onder M., et al. Clinical features and natural course of Behçet's disease in 661 cases: a multicenter study. Br J Dermatol 2007, 157:901-906.
20. International Study Group for Behçet's Disease Criteria for diagnosis of Behçet's disease. Lancet 1990, 335:1078-1080.
21. Wray D., Graykowski E.A., Notkins A.L. Role of mucosal injury in initiating recurrent aphthous stomatitis. Br Med J (Clin Res Ed) 1981, 283:1569-1570.
22. Sharquie K.E., Al-Araji A., Hatem A. Oral pathergy test in Behçet's disease. Br J Dermatol 2002, 146:168-169.
23. Mat C., Goksugur N., Ergin B., et al. The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective study. Int J Dermatol 2006, 45:554-556.
24. Demirkesen C., Tüzüner N., Mat C., et al. Clinicopathologic evaluation of nodular cutaneous lesions of Behcet syndrome. Am J Clin Pathol 2001, 116:341-346.
25. Tunç R., Saip S., Siva A., Yazici H. Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome. Ann Rheum Dis 2004, 63:1693-1694.
26. Kucukoglu S., Tunc R., Cetinkaya F., et al. The importance of cutaneous ultrasonography on the differentiation of nodular skin lesions seen in patients with Behcet's disease. Yonsei Med J 2000, 41:40.
27. Alpsoy E., Aktekin M., Er H., et al. A randomized, controlled and blinded study of papulopustular lesions in Turkish Behçet's patients. Int J Dermatol 1998, 37:839-842.
28. Hatemi G., Bahar H., Uysal S., et al. The pustular skin lesions in Behcet's syndrome are not sterile. Ann Rheum Dis 2004, 63:1450-1452.
29. Ergun T., Gürbüz O., Doǧusoy G., Mat C. Histopathologic features of the spontaneous pustular lesions of Behçet's syndrome. Int J Dermatol 1998, 37:194-196.
30. Diri E., Mat C., Hamuryudan V., Yurdakul S., Hizli N., Yazici H. Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 2001, 60:1074-1076.
31. Hatemi G., Fresko I., Taşcilar K., Yazici H. Entesopathy is increased among Behçet's syndrome patients with acne and arthritis: an ultrasonographic study. Arthritis Rheum 2008, 58:1539-1545.
32. Oǧuz O., Serdaroǧlu S., Tüzün Y., et al. Acute febrile neutrophilic dermatosis associated with Behcet's syndrome. Int J Dermatol 1992, 31:645-646.
33. Azizlerli G., Ozarmaǧan G., Ovül C., Sarica R., Mustafa S.O. A new kind of skin lesion in Behçet's disease: extragenital ulcers. Acta Derm Venereol 1992, 72:286.
34. Altaç M., Tüzün Y., Yurdakul S., et al. The validity of the pathergy test (non-specific skin hyperreactivity) in Behçet's disease: a double-blind study by independent observers. Acta Derm Venereol 1982, 62:158-159.
35. Yazici H., Tüzün Y., Tanman A.B., et al. Male patients with Behçet's syndrome have stronger pathergy reactions. Clin Exp Rheumatol 1985, 3:137-141.
36. Yazici H., Chamberlain M.A., Tüzün Y., Yurdakul S., Müftüoglu A. A comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease. Ann Rheum Dis 1984, 43:74-75.
37. Dilşen N., Koniçe M., Aral O., Ocal L., Inanç M., Gül A. Comparative study of the skin pathergy test with blunt and sharp needles in Behçet's disease: confirmed specificity but decreased sensitivity with sharp needles. Ann Rheum Dis 1993, 52:823-825.
38. Tugal-Tutkun I., Onal S., Altan-Yaycioglu R., et al. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 2004, 138:373-380.
39. Özyazgan Y., Bodaghi B. Eye disease in Behçet's syndrome. Behçet's Syndrome 2010, 73-94. Springer, New York. 1st ed. Y. Yazici, H. Yazici (Eds.).
40. Yurdakul S., Yazici H., Tüzün Y., Pazarli H., Yalçin B., Altaç M. The arthritis of Behçet's disease: a prospective study. Ann Rheum Dis 1983, 42:505-515.
41. Yazici H., Tuzlaci M., Yurdakul S. A controlled survey of sacroiliitis in Behçet's disease. Ann Rheum Dis 1981, 40:558-559.
42. Ideguchi H., Suda A., Takeno M., et al. Characteristics of vascular involvement in Behçet's disease in Japan: a retrospectif cohort study. Clin Exp Rheumatol 2011, 29:47-53.
43. Seyahi E., Yurdakul S. Behçet's syndrome and thrombosis. Mediterr J Hematol Infect Dis 2011, 3. e2011026. (Epub 2011 Jul 8.).
44. Bayraktar Y., Balkanci F., Bayraktar M., Calguneri M. Budd-Chiari syndrome: a common complication of Behçet's disease. Am J Gastroenterol 1997, 92:858-862.
45. Saadoun D., Asli B., Wechsler B., et al. Long-term outcome of arterial lesions in Behçet disease: a series of 101 patients. Medicine (Baltimore) 2012, 91:18-24.
46. Hamuryudan V., Er T., Seyahi E., et al. Pulmonary artery aneurysms in Behçet syndrome. Am J Med 2004, 117:867-870.
47. Ozkan M., Emel O., Ozdemir M., et al. M-mode, 2-D and Doppler echocardiographic study in 65 patients with Behçet's syndrome. Eur Heart J 1992, 13:638-641.
48. Geri G., Wechsler B., Thi Huong du L., et al. Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of literature. Medicine (Baltimore) 2012, 91:25-34.
49. Cheon J.H., Çelik A.F., Kim W.H. Behçet's disease: gastrointestinal involvement. Behçet's Syndrome 2010, 165-188. Springer, New York. 1st ed. Y. Yazici, H. Yazici (Eds.).
50. Akman-Demir G., Serdaroǧlu P., Tasci B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. Brain 1999, 122:2171-2182.
51. Siva A., Kantarci O.H., Saip S., et al. Behçet's disease; diagnostic and prognostic aspects of neurological involvement. J Neurol 2001, 248:95-103.
52. Ideguchi H., Suda A., Takeno M., et al. Neurological manifestations of Behçet's disease in Japan: a study of 54 patients. J Neurol 2010, 257:1012-1020.
53. Uluduz D., Kürtüncü M., Yapici Z., et al. Clinical characteristics of pediatric onset neuro-Behçet's disease. Neurology 2011, 77:1900-1905.
54. de Menthon M., Lavalley M.P., Maldini C., Guillevin L., Mahr A. HLAB51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case control genetic association studies. Arthritis Rheum 2009, 61:1287-1296.
55. Sakaguchi T., Ibe M., Miwa K., et al. Predominant role of N-terminal residue of nonamer peptides in their binding to HLA-B*5101 molecules. Immunogenetics 1997, 46:245-248.
56. Duymaz-Tozkir J., Uyar A.F., Norman P.J., et al. Distribution of killer immunoglobulin like receptor 3DL1/3DS1 alleles in Behçet's disease. Arthritis Rheum 2008, 58(Suppl.):S855.
57. Meguro A., Inoko H., Ota M., et al. Genetics of Behçet's disease inside and outside the MHC. Ann Rheum Dis 2012, 69:747-754.
58. Maldini C., Lavalley M.P., Cheminant M., et al. Relationships of HLA-B51 or B5 genotype with Behçet's disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology (Oxford) 2012, 51:887-900.
59. Remmers E.F., Cosan F., Kirino Y., et al. Genome-wide association study identifies variants in the MHC class I, IL10 and IL-23R-IL12RB2 regions associated with Behçet's disease. Nat Genet 2010, 42:698-702.
60. Mizuki N., Meguro A., Ota M., Ohno S., Shiota T., Kawagoe T. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet 2010, 42:703-706.
61. Fresko I. 15th International Congress on Behçet's Disease 13-15 July 2012, Yokohama, Japan. Clin Exp Rheumatol 2012, 30(Suppl. 72):S118-S128.
62. Direskeneli H., Fujita H., Akdis C.A. Regulation of Th17 and regulatory T cells in patients with Behçet's disease. J Allergy Clin Immunol 2011, 128:665-666.
63. Hamzaoui K. Th17 cells in Behçet's disease: a new immunoregulatory axis. Clin Exp Rheumatol 2011, 29(Suppl. 67):S71-S76.
64. Geri G., Terrier B., Rosenzwajg M., Wechsler B., Touzot M., Seilhean D. Critical role of IL-21 in modulating Th17 and regulatory T cells in Behçet's disease. J Allergy Clin Immunol 2011, 128:655-664.
65. Kim J., Park J.A., Lee E.Y., Lee Y.J., Song Y.W., Lee E.B. Imbalance of Th17 to Th1 cells in Behçet's disease. Clin Exp Rheumatol 2010, 28(Suppl. 60):S16-S19.
66. Ferrante A., Ciccia F., Principato A., et al. A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease. Clin Exp Rheumatol 2010, 28(Suppl. 60):S27-S30.
67. Tunc R., Keyman E., Melikoglu M., Fresko I., Yazici H. Target organ associations in Turkish patients with Behçet's disease: a cross sectional exploratory factor analysis. J Rheumatol 2002, 29:2393-2396.
68. Yazici H., Ugurlu S., Seyahi E. Behçet's Syndrome: is it one condition?. Clin Rev Allergy Immunol 2012, 43:275-280.
69. Karaca M., Hatemi G., Sut N., Yazici H. The papulopustular lesion/arthritis cluster in Behçet's syndrome also clusters in families. Rheumatology (Oxford) 2012, 51:1053-1060.
70. Stojanov S., Kastner D.L. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005, 17:586-599.
71. Musabak U., Pay S., Erdem H., et al. Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?. Rheumatol Int 2006, 545-550.
72. Rabinovich E., Shinar Y., Leiba M., et al. Common FMF alleles may predispose to development of Behçet's disease with increased risk for venous thrombosis. Scand J Rheumatol 2007, 36:48-52.
73. Yazici H., Fresko I. Behçet's disease and other autoinflammatory conditions: What is in a name?. Clin Exp Rheumatol 2005, 23(4Suppl 38):S1-S2.